Development
Xylem Inc.
XYL
$125.13
-$0.24-0.19%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 33.36% | 26.47% | 15.93% | 9.35% | 6.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.36% | 26.47% | 15.93% | 9.35% | 6.29% |
| Cost of Revenue | 35.17% | 26.63% | 15.12% | 8.60% | 6.90% |
| Gross Profit | 30.37% | 26.20% | 17.28% | 10.58% | 5.31% |
| SG&A Expenses | 31.45% | 26.12% | 12.21% | 5.43% | 3.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.27% | 25.82% | 13.83% | 7.43% | 5.81% |
| Operating Income | 34.01% | 31.78% | 33.88% | 25.45% | 10.14% |
| Income Before Tax | 44.32% | 62.86% | -9.53% | -5.45% | -13.89% |
| Income Tax Expenses | -69.41% | 110.34% | 30.56% | 31.51% | 1.19% |
| Earnings from Continuing Operations | 71.55% | 54.23% | -16.39% | -11.85% | -16.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.55% | 54.23% | -16.39% | -11.85% | -16.86% |
| EBIT | 34.01% | 31.78% | 33.88% | 25.45% | 10.14% |
| EBITDA | 47.16% | 38.21% | 27.90% | 17.74% | 6.41% |
| EPS Basic | 38.92% | 38.73% | -19.16% | -11.90% | -16.90% |
| Normalized Basic EPS | 14.44% | 22.95% | 36.46% | 34.39% | 16.92% |
| EPS Diluted | 38.86% | 38.71% | -19.25% | -11.82% | -16.78% |
| Normalized Diluted EPS | 14.12% | 22.83% | 36.49% | 34.68% | 17.26% |
| Average Basic Shares Outstanding | 20.24% | 11.89% | 3.49% | -0.01% | -0.04% |
| Average Diluted Shares Outstanding | 20.56% | 12.06% | 3.50% | -0.19% | -0.30% |
| Dividend Per Share | 10.00% | 9.32% | 8.62% | 7.89% | 7.14% |
| Payout Ratio | -0.20% | -0.17% | 0.39% | 0.22% | 0.29% |